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Abstract 
Controlling the cell-substrate interactions at the bio-interface is becoming an inherent element in the 
design of implantable devices. Modulation of cellular adhesion in vitro, through topographical cues, 
is a well-documented process that offers control over subsequent cellular functions. However, it is 
still unclear whether surface topography can be translated into a clinically functional response in 
vivo at the tissue / device interface. Herein, we demonstrated that anisotropic substrates with a 
groove depth of ~317 nm and ~1,988 nm promoted human tenocyte alignment parallel to the 
underlying topography in vitro. However, the rigid poly(lactic-co-glycolic acid) substrates used in 
this study upregulated the expression of chondrogenic and osteogenic genes, indicating possible 
tenocyte trans-differentiation. Of significant importance is that none of the topographies assessed 
(~37 nm, ~317 nm and ~1,988 nm groove depth) induced extracellular matrix orientation parallel to 
the substrate orientation in a rat patellar tendon model. These data indicate that two-dimensional 
imprinting technologies are useful tools for in vitro cell phenotype maintenance, rather than for 
organised neotissue formation in vivo, should multifactorial approaches that consider both surface 
topography and substrate rigidity be established. 
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1. Introduction 
Given the poor inherent regeneration capability of tendons, largely attributed to low vascularity and 
low activity cellular content, intervention strategies should be developed to promote functional 
tendon repair and regeneration. Given that tissue graft based therapies have failed to restore native 
tendon function, it is anticipated that the tissue-engineering arpeggio (scaffolds, cells, biologics 
alone or in combination) would provide a functional therapy in the years to come [1-13]. 
Biomaterials’ design and development is coming ever closer to mimicking native extracellular 
matrix (ECM) assemblies, as advancements in engineering have allowed development of two- and 
three- dimensional substrates with precise mechano-architectural and chemical properties. Indeed, 
current biomaterial fabrication technologies not only achieve structural support, but also maintain 
permanently differentiated cell phenotype and/or direct lineage commitment of stem cells. For 
example, topographical features have been shown to maintain Oct4 expression in human embryonic 
stem cell culture, even in the absence of basic fibroblast growth factor supplementation [14]; 
topographical cues alone [15, 16] or in combination with neurotrophic signals [17] have also been 
shown to enhance contact guidance and neuronal differentiation of human neural stem cells in vitro. 
Topographical cues have been shown to enhance myogenic differentiation and maturation of 
myoblasts [18] and to induce myogenic commitment of human mesenchymal stem cells in vitro 
[19]. Surface topography alone [20] or in combination with substrate rigidity [21] have been shown 
to control mesenchymal stem cell lineage commitment. Recently, multi-scale patterned substrates 
have been shown to control adhesion and differentiation of human mesenchymal stem cells [22] and 
topographical features combined with hyaluronic acid have been shown to enhance chondrogenic 
differentiation of dental pulp stem cells [23]. Furthermore, two-dimensional and three-dimensional 
patterning technologies have been shown to enhance osteo-induction of stem cells [24], whilst 
proliferation and osteogenic differentiation of human mesenchymal stem cells have been shown to 
be dependent on the size of the underlying structures [25]. However, optimal feature geometries and 
conformations (e.g. grooves, pillars) and dimensionality (e.g. nano, micro) of such topographical 
  
features remain elusive, despite significant scientific achievements and technological innovations in 
fabrication processes and in vitro analysis. 
To date, two- and three- dimensional scaffold fabrication technologies (e.g. electro-spinning [26-
31], fibre extrusion [32-35], isoelectric focusing [36, 37] and imprinting [38-40]) have been at the 
forefront of scientific and technological research and innovation to recapitulate native tendon 
extracellular matrix (ECM) supramolecular assemblies. Although fibrous constructs (e.g. electro-
spun polymeric fibres, extruded collagen fibres and isoelectrically focused collagen fibres) have 
been shown to maintain tenocyte phenotype and to differentiate stem cells towards tenogenic 
lineage in vitro and to induce acceptable regeneration in preclinical models, none of these 
technologies offers precise control over the spatial distribution of the fibres. Imprinting 
technologies, on the other hand, have demonstrated a diverse effect on a range of permanently 
differentiated and stem cell functions, including adhesion, orientation, secretome expression and 
lineage commitment [41-48] and offer significantly greater control over feature dimension and 
spacing. Specifically to tendon repair, such technologies have been shown to maintain tenocyte 
phenotype [38]; to promote aligned tendon-specific ECM deposition [39]; and to differentiate stem 
cells towards tenogenic lineage [40]. Despite these advancements, a comprehensive study on the 
influence of surface features with respect to the modulation of tenocyte phenotype in vitro through 
anisotropic nano- to micron- scale topographies and on tissue response in vivo has yet to be 
elucidated. Thus, in the present study, we employed imprint lithography to create anisotropically 
grooved substrates with constant width and spacing and varying depth, as opposed to isotropic 
topography, to study tenocyte function in vitro and the host tissue response in vivo. 
  
2. Materials and Methods 
2.1. Anisotropic substrate fabrication 
The process of substrate fabrication has been described previously [49]. Briefly, Si master moulds 
with anisotropic topographies were fabricated via a photolithography process, followed by reactive 
ion etching (RIE). 1.5 x 1.5 cm2 regions were patterned with lines / gratings of 2,101.78 ± 35.21 nm 
and 1,911.42 ± 37.50 nm widths respectively, and variable groove depths (37.48 ± 3.4 nm, 317.29 ± 
7.05 nm and 1,988.2 ± 195.3 nm). Silicon wafers (3.0 x 3.0 cm2) were spin-coated with a positive 
photoresist (S1813 PR, Shipley) and then exposed using OAI Mask Aligner (Model MBA800). 
Following photoresist development, the master mould was etched by RIE (Oxford ICP etcher) using 
CHF3 + SF6 ionised gas. The moulds were silanised with 5 mM octadecyltrichlorosilane (OTS, 
Sigma Aldrich, Ireland) solution to facilitate imprint release. A thermal imprinting process was used 
to transfer the master pattern into a 2.0 x 2.0 cm2 PLGA substrate (85:15, Sigma Aldrich, Ireland) 
using a Specac Hydraulic Press (15 T & 25 T) at 120 °C and a pressure of 5 MPa, for 5 min. The 
imprinted gratings on polymer were subsequently analysed by SEM and AFM. Non-imprinted 
PLGA substrates were used as isotropic control substrates. 
 
2.2. Surface chemical analysis 
X-ray photoelectron spectroscopy (XPS) analysis was performed in a Kratos AXIS 165 X-ray 
photoelectron spectrometer using monochromatic Al Kα radiation of energy 1486.6 eV and 
operated at beam voltage of 15 kV and beam current of 10 mA. High-resolution spectra of O 1s, C 
1s and Si 2p were taken at fixed pass energy of 20 eV. Construction and peak fitting of synthetic 
peaks in narrow region spectra used a Shirely type background and the synthetic peaks were of a 
mixed Gaussian-Lorenzian type. Relative sensitivity factors used are from CasaXPS library 
containing Scofield cross-sections. Binding energies were determined using C 1s peak at 284.8 eV 
as charge reference. 
 
  
2.3. Human tenocyte culture 
Human primary tenocytes (positive for tenomodulin, scleraxis and tenascin C; Cambridge 
Biosciences, UK) were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented 
10 % foetal bovine serum and 1 % penicillin/streptomycin (all Sigma Aldrich, Ireland). Cells were 
maintained at 37 °C and 5 % carbon dioxide, with the media being changed every 3 days. Tenocytes 
were sub-cultured when 80 % confluency was reached. Tenocytes were detached from the culture 
flask with trypsin-EDTA solution (Sigma Aldrich, Ireland) and then seeded on the imprinted and 
isotropic substrates in 12-well (Ibidi®, Germany) and 8-well (Lab-Tek™, Thermo Scientific, UK) 
chamber slides at a cell density of 20,000 cells per 1 cm2 for morphometric, viability, proliferation 
and metabolic activity analyses and 25,000 cells per 1 cm2 for gene expression analysis (sufficient 
quality and quantity of RNA was obtained at this density), respectively. All in vitro experiments 
were conducted for 1, 5, and 10 days and cells at passage 3 were used. 
 
2.4. Human tenocyte morphometric analysis 
Immunofluorescent images were used to evaluate cell morphology and alignment. At the end of 
culture points, the substrates were washed three times with Hanks Balanced Salt Solution (HBSS, 
Sigma Aldrich, Ireland) and the cells were fixed with 4 % paraformaldehyde (Sigma Aldrich, 
Ireland) for 15 min at room temperature (RT). The cells were washed again in HBSS three times 
and then permeabilised with 0.2 % Triton X (Sigma Aldrich, Ireland) for 5 min. The cells were then 
exposed to 4’,6-diamidino-2-phenylindole (DAPI, Molecular Probes, Ireland) in phosphate buffer 
saline (PBS) for 5 min, washed with HBSS and then exposed to rhodamine conjugated phalloidin 
(Molecular Probes, Ireland) in PBS for 1 h. Images were captured with a 10X objective, using an 
inverted BX51 Olympus fluorescence microscope (Olympus, Japan). 
Immunofluorescent micrographs of tenocytes were quantitatively analysed using ImageJ software 
(NIH). Briefly, images were converted to 8-bit grey scale and threshold to distinguish cellular 
outlines from the non-cellular background signal; the program detected cells on the basis of contrast 
  
and fitted the cellular outlines to equivalent ellipses. The following cell shape characteristics were 
measured for each fitted ellipse: major axis, minor axis, aspect ratio (major axis / minor axis), 
perimeter, area, and orientation angle with respect to the direction of grooves. Cellular orientation / 
alignment was determined by the angle between the major axis of the cell and the groove direction. 
The angle for each cell was converted such that 0 ° represented cell orientation along the direction 
of the grooves and 90 ° represented a perpendicular orientation, with respect to the direction of the 
grooves. Cells within 10 ° of the groove direction were considered aligned. Cell morphology was 
quantified using aspect ratio (major axis/minor axis). Aspect ratio was used to evaluate cellular 
elongation, with a higher aspect ratio indicating increased elongation. Cells that overlapped or 
aggregated together or wherever boundaries of contacting cells could not be distinguished clearly 
were not used for quantitative analysis. Approximately, two hundred cells per group were used to 
assess the influence of surface topography on cellular morphology. 
 
2.5. Human tenocyte viability, metabolic activity and proliferation 
Live/Dead® assay (BioSource International, Invitrogen, Ireland) was performed on days 1, 5 and 10 
to assess cellular viability, as per manufacturer’s protocol. Briefly, cells were washed 3 times with 
HBSS and exposed to the staining solution of calcein and ethidium homodimer. The cells were 
incubated at 37 °C for 45 min. Following staining, the cells were viewed using the BX51 Olympus 
fluorescence microscope and analysed using ImageJ. 
Cell metabolic activity was determined using alamarBlue® assay on days 1, 5, and 10, as per 
manufacturer’s protocol. Briefly, alamarBlue® dye was diluted with HBSS to make a 10 % (v/v) 
alamarBlue® solution. Media was removed from each well and 0.5 ml alamarBlue® solution was 
added to each well. Cell were incubated for 3 h at 37 °C; the absorbance of the alamarBlue® was 
measured at wavelengths of 550 nm and 595 nm using a micro plate reader (Varioskan Flash, 
Thermo Scientific, UK). The level of metabolic activity was calculated using the simplified method 
of calculating % reduction, according to the supplier’s protocol. 
  
Cell proliferation was assessed on days 1, 5, and 10, by counting DAPI stained cell nuclei, using the 
BX51 Olympus fluorescence microscope (please see section 2.3 for more details). 
All experiments (viability, metabolic activity and proliferation) were repeated in three independent 
experiments and each experiment was performed in triplicate. 
 
2.6. Human tenocyte gene expression analysis 
A comprehensive gene expression analysis was conducted using TaqMan® Low Density Array 
(TLDA; Applied Biosystems, UK), grouping genes of interest as collagenous, non-collagenous, 
adhesion and housekeepers (Table 1). 
Cell density of 25,000 cells per 1 cm2 was seeded on the substrates and total RNA was extracted 
from human tenocytes on days 0, 1, 5 and 10. Total RNA was extracted using Trizol reagent 
method. Briefly, Trizol (400 µg/well, Sigma Aldrich, UK) was added to the cells for 15 min to 
disrupt the cellular membranes. Then, the Trizol solution was collected and chloroform (Sigma 
Aldrich, UK) was added to the solution and shaken vigorously for 15 sec. RT incubation for 5 min 
was followed. Then the upper aqueous phase containing the RNA was removed and mixed with 
isopropanol (Sigma Aldrich, UK) to obtain a pure RNA pellet. Subsequently, the RNA was used for 
the reverse-transcriptase reaction to synthesize the first strand of cDNA. cDNA (100 ng) and 
universal PCR mastermix (50 µl) were loaded into the fill reservoirs (100 µl / reservoir) and the 
plate was run according to manufacturer’s instructions, using the Applied Biosystems 7900HT 
Real-Time PCR System and Applied Biosystems Sequence Detection Systems (SDS 2.3 and RQ 
manager 1.2) software. The thermal cycles were as follows: 50 °C for 2 min, 94.5 °C for 10 min, 
followed by 40 cycles of 97 °C for 30 sec and 59.7 °C for 1 min. Using the 2-∆Ct method, mean Ct 
values of each target gene was normalised to the housekeeping gene values. To analyse the changes 
in gene expression between the isotropic control and the anisotropic substrates for each day, 2-∆∆Ct 
method was used. The gene expression was then evaluated using hierarchical clustering software 
  
(IPA software of complex ‘omics data, Ingenuity® systems, Qiagen, USA) with the fold change 
compared to the time point control and a threshold set at 1.4. 
 
2.7. In vivo study and analysis 
The Animal Care Research Ethics Committee of NUI Galway approved all experimental protocols. 
For the tendon model, female Lewis rats (200g – 250g) were used, following a protocol described 
previously [50]. Briefly, surgery was performed under general anaesthesia. A small incision was 
made to the side of the knee, exposing the patellar tendon by moving the skin and opening the 
fascia. Using a punch biopsy, a 2mm in diameter circular defect was created at the centre of the 
tendon, allowing the creation of a consistent and reproducible injury, without compromising the 
mechanical integrity of the tendon. The tendon was wiped dry using sterile gauze. Circular sections 
of the structured substrates (2 mm in diameter) were secured at the injury site using a PLGA film, 
secured in place with sutures. The grooved substrates were aligned parallel to the gross tendon 
orientation (Figure 1). Following euthanisation, tissue samples were harvested at weeks 2, 4 and 
12, fixed in 4% paraformaldehyde (Sigma Aldrich, Ireland), stored in sucrose (Sigma Aldrich, 
Ireland) and then fixed in freezing compound (Sigma Aldrich, Ireland). Twelve animals were used 
at each time point and structured substrates and autografts were randomly assigned to each 
contralateral patellar tendon. Cryo-sectioning was performed at Histotech (University of York, 
UK0. Sections (10 µm thick) were cut using a Leica CM 1950 cryostat (Leica Microsystems, 
Germany) on manual setting, operating at -20 °C and collected onto Superfrost® Plus glass slides 
(Thermo Scientific, UK). Sections were air dried at ambient temperature for 1 hour and stored 
desiccated at -80ºC until use. Tissue sections were then stained with haematoxylin-eosin (Sigma 
Aldrich, Ireland) and images were captured with an Olympus IX-81 inverted microscope (Olympus 
Corporation, Tokyo, Japan). Tissue sections were also stained with Picrosirius Red (Sigma Aldrich, 
Ireland) and images were captured with an Olympus polarised light microscope (Olympus 
Corporation, Tokyo, Japan). Picrosirius Red images were also used for quantitative tissue 
  
morphometric analysis (ImageJ). For the subcutaneous study, female Lewis rats (200g – 250g) were 
used, following a protocol described previously [51]. Briefly, surgery was performed on rats under 
general anaesthesia. Incisions were made at the back of each animal, allowing insertion of a 0.5 cm 
x 0.5 cm structured substrate. The wound was then closed, using biodegradable sutures. Following 
euthanisation, the substrates were harvested at days 2 and 14 and were stained using DAPI and 
rhodamine conjugated phalloidin. Three animals were used per time point and at each animal all 
three structured substrates were implanted. Images were captured with an Olympus IX-81 inverted 
microscope (Olympus Corporation, Tokyo, Japan). 
 
2.8. Statistical analysis 
All data were analysed using GraphPad Prism® 5 (GraphPad Software, USA) and/or PASW 
Statistics 17.0 (SPSS Inc, IL). Analysis of variance (ANOVA) and Tukey’s multiple comparison 
post-hoc tests were performed after confirming the following assumptions: (a) the distribution from 
which each of the samples was derived was normal; and (b) the variances of the population of the 
samples were equal to one another. Statistical significance was accepted at p < 0.05. 
  
  
3. Results 
3.1. Substrate analysis 
Anisotropic PLGA substrates with constant groove and line width of 1,911.42 ± 37.50 nm and 
2,101.78 ± 35.21 nm respectively and variable groove depth of 37.48 ± 3.4 nm, 317.29 ± 7.05 nm 
and 1,988.2 ± 195.3 nm were fabricated using standard photolithography followed by imprinting 
lithography. Isotropic / quasi-planar PLGA substrates were used as control, with an inherent Ra of 
80.17 ± 28.92 nm over 10 µm2 (Figure 2). Surface chemical analysis indicated that no significant 
differences in elemental composition were present amongst all experimental topographical groups 
(Figure 3). XPS spectra presented well-defined peaks corresponding to the presence of C, O and Si 
on all substrates. A reduction in O and an increase in C content were observed on control substrates 
relative to topographical substrates. Critically, octadecyltrichlorosilane contamination was not 
present, as assessed by the absence of a chlorine peak at 198-200 eV. 
 
3.2. Human tenocyte morphometric analysis as a function of topography 
Gross visual analysis of immunofluorescent images revealed that at all time points (1, 5 and 10 
days), human tenocytes exhibited spread morphology on isotropic and imprinted substrates with 
groove depth of ~37 nm (Figure 4A). An aligned orientation and an elongated morphology, parallel 
to the substrate topography, was observed as early as 24 h in culture and was maintained for up to 
10 days (longer culture time point assessed) on imprinted substrates with groove depth of ~317 nm 
and ~1,988 nm (Figure 4A). 
Subsequently, a detailed quantitative analysis was carried out to assess the influence of the various 
topographies, including isotropic controls, on cellular morphometry. Tenocytes on isotropic 
controls and ~37 nm in depth substrates exhibited random alignment / orientation, with the major 
axis of the cells evenly distributed over 90 °. Whereas by increasing the groove depth to ~317 nm 
and ~1,988 nm, 80 % and 100 % respectively cellular alignment / elongation parallel to the 
substrate topography was observed (Figure 4B). Although cellular area (Figure 4C) and nuclei 
  
aspect ratio (Figure 4E) were not significantly affected (p > 0.05) as a function of the substrate 
topography, cellular aspect ratio was significantly increased (p < 0.005; Figure 4D) as a function of 
increasing groove depth, resulting in increasingly fusiform tenocyte morphology. Indeed, tenocytes 
seeded on the isotropic and ~37 nm in depth substrates exhibited cellular aspect ratio of 
approximately 4, whereas by increasing the groove depth to ~317 nm and ~1,988 nm, the aspect 
ratio was increased to approximately 11 and 16 respectively. 
 
3.3. Human tenocyte viability, metabolic activity and proliferation analysis as a function of 
topography 
No significant differences (p > 0.05) in human tenocyte viability (Figure S1A), metabolic activity 
(Figure S1B) and proliferation (Figure S1C) were observed at any time point (1, 5 and 10 days), as 
a function of the different topographies relative to isotropic controls. 
 
3.4. Human tenocyte gene analysis as a function of topography 
Hierarchal clustering of the fold change (threshold of 1.4) in gene expression of human tenocytes on 
the anisotropic substrates, as compared to the isotropic control substrates, at the corresponding time 
points (day 1, 5 and 10) is presented in Figure 5. At day 1, an overall gene upregulation (e.g. 
collagenous, non-collagenous and adhesion) was observed only in tenocytes cultured on substrates 
with groove depth of 1,988 nm, whilst at day 10 tenocytes cultured on substrates with groove depth 
~317 nm and ~1,988 nm were associated with more genes that were significantly upregulated than 
substrates with groove depth ~37 nm. At day 10, IBSP (bone sialoprotein) and ACAN (aggrecan) 
were significantly upregulated on all substrates. 
 
3.5. Host tissue response as a function of topography 
Haematoxylin-eosin staining at the tendon repair site showed a disorganised collagen fibre pattern 
for all anisotropic substrates (Figure 6), which was further verified with Picrosirius Red staining 
  
(Figure 7). By week 12, collagen fibres from all treatments changed from green, indicative of 
collagen type III, to yellow / red, indicative of collagen type I (Figure 7). Complementary 
morphometric analysis of tendon fibre alignment demonstrated that only non-injured tendons had 
100 % fibre distribution between -5 to 5 °, whilst the rest treatments exhibited less than 65% fibre 
distribution between -5 to 5 ° (Figure 8). In a subcutaneous model, when structured substrates were 
explanted and stained for DAPI and rhodamine conjugated phalloidin, no apparent cellular 
alignment was evidenced (Figure S2). 
  
  
4. Discussion 
Herein, we ventured to investigate the impact of groove depth (~37 nm, ~317 nm and ~1,988 nm), 
whilst maintain groove width (~1,911 nm) and line width (~2,102 nm) constant, on human tenocyte 
morphology and gene expression in vitro and on directional neotissue formation in vivo. The groove 
dimensions were selected on the basis that closely represent the topographical cues (dimensionality 
of collagen fibrils is in the region of 10 to 1,000 nm, whilst the dimensionality of collagen fibres is 
in the region of 1,000 to 20,000 nm [12]) that tenocytes are exposed to in vivo. The micro-scale 
groove depth was selected based on previous publications, where authors supported that pitch 
dimensionality smaller than 4000 nm induces efficient cellular contact guidance [40, 42, 52]. 
Furthermore, the cellular response to underlying topographies is enhanced when the feature pitch is 
similar to or smaller than the dimensions of the cell type being studied [53], facilitating contact with 
more than one discontinuity. This approach allows for directional alignment of the cells without 
physically restricting cells within individual groove features [54]. 
With respect to the morphometric analysis, it was observed that isotropic (control) substrates and 
substrates with a groove depth of ~37 nm, failed to induce any morphological changes in cultured 
tenocytes. Conversely, substrates with deeper grooves (~317 nm and ~1,988 nm) induced 
significant changes to the cytoskeleton morphology, but did not significantly influence nuclei 
morphology. Although, the mechano-transduction theory proposes that intracellular tension in 
elongated and aligned cytoskeleton actin filaments is transferred to the nucleus through cytoskeletal 
elements [55-60], this indifference in nuclei morphology may be attributed to the short time after 
culture on grooved substrates that nuclei aspect ratio was assessed. 
No significant difference was observed in cell metabolic activity, viability and proliferation, 
between the experimental groups. This observation indicates that although both topography and 
mechanical stretching can induce similar bidirectional cell elongation, only mechanical loading, in 
excessive form, can activate apoptotic pathways [61-64]. 
  
Gene analysis clearly indicates that only substrates with groove depth of ~1,988 nm induced 
immediate (day 1) upregulation effects on cultured tenocytes, which was maintained for all culture 
time points. However, by day 10, bone sialoprotein, osteonectin, runt-related transcription factor 2, 
cartilage oligomeric protein and aggrecan were significantly upregulated on substrates with groove 
depth ~1,988 nm and bone sialoprotein and aggrecan were significantly upregulated on all 
substrates. These observations indicate possibly trans-differentiation of tenocytes towards 
osteogenic / chondrogenic lineage. Indeed, bone sialoprotein encodes non-collagenous components 
of bone ECM; runt-related transcription factor 2 promotes osteogenic differentiation; and 
osteonectin is a bone-specific protein that binds selectively to hydroxyapatite and collagen [65-68]. 
Similarly, cartilage oligomeric protein and aggrecan, although persistent in tendon, are primarily 
considered cartilage-specific molecules, mutations of which are associated with skeletal 
pathophysiologies [69-72]. We attribute this indicative trans-differentiation to the far from 
physiological substrate stiffness of the PLGA material employed in this study. Indeed, substrate 
stiffness has been shown to strongly regulate protein expression, cell phenotype maintenance and 
stem cell differentiation, with soft substrates observed to be neurogenically conductive and rigid 
substrates to be chondrogenic / osteogenic [73-76]. This implies that multifactorial, rather than 
mono-domain, approaches should be assessed in future studies, in accordance with previous 
observations, where it was suggested that topography should be combined with mechanical loading 
for physiological bovine tenocyte morphology maintenance [27]. 
Critically, herein, the in vitro work was followed up with two in vivo studies to elucidate the 
efficacy of nano and micro-scale topographical functionalisation in de novo tissue regeneration. 
None of the structured substrates induced neotissue formation parallel to the substrate topography in 
a tendon model. Further, in a subcutaneous model, none of the substrates induced cellular 
orientation parallel to the direction of the substrate topography. It is tempting to hypothesise that 
two-dimensional imprinted substrates are overwhelmed with body fluids and protein adsorption 
upon implantation, prohibiting favourable cell / material interaction at the substrate-tissue nano-bio-
  
interface and that three-dimensional fibrous constructs are more effective for directional neural [77-
79], tendon [29, 35, 80], bone [81-83] and skin [84-86] neotissue formation and promote relatively 
enhanced cell growth, motility, matrix deposition and neotissue growth through the provision of a 
true three-dimensional environment.  
  
  
5. Conclusions 
Herein, we demonstrated that low nano topographical features (~37 nm groove depth) were not 
sufficient to induce physiological tenocyte morphology, as compared to ~317 nm and ~1,988 nm 
groove depth substrates. In two different animal models, the structured substrates failed to induce 
parallel to the underlined topography directional host cell growth and neotissue formation. Further, 
the rigid substrates used upregulated gene expression of bone and cartilage genes, suggesting 
tenocyte trans-differentiation towards osteogenic and chondrogenic lineages, respectively. 
Collectively, these data indicate that three-dimensional fibrous constructs are more promising for 
directional neotissue formation, whilst two-dimensional imprinted substrates can be used for 
optimal cell expansion in vitro, should multifactorial approaches that consider both surface 
topography and substrate stiffness be established. 
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7. Tables 
Table 1: Genes and their transcripts, grouped as collagenous, non-collagenous, adhesion and 
housekeepers. 
Gene Name Gene Symbol NCBI Ref. Seq. TaqMan® Transcript 
Collagenous 
Collagen I COL1A1 NM_000088.3 Hs00164004_m1 
Collagen III COL3A1 NM_000090.3 Hs00943809_m1 
Collagen IV COL4A1 NM_001845.4 Hs00266237_m1 
Collagen V COL5A1 NM_000093.3 Hs00609088_m1 
Collagen VI COL6A1 NM_001848.2 Hs00242448_m1 
Collagen XI COL11A1 NM_001854.3 Hs01097664_m1 
Collagen XII COL12A1 NM_004370.5 Hs00189184_m1 
Collagen XIV COL14A1 NM_021110.1 Hs00966234_m1 
Non-collagenous 
Scleraxis Homolog A SCXA NM_001008271.1 Hs03054634_g1 
Tenascin C TNC NM_002160.3 Hs01115665_m1 
Biglycan BGN NM_001711.4 Hs00156076_m1 
Decorin DCN NM_001920.3 Hs00370384_m1 
Osteopontin SPP1 NM_00058.2 Hs00959010_m1 
Alkaline Phosphatase ALPL NM_000478.4 Hs01029144_m1 
Bone Sialoprotein IBSP NM_004967.3 Hs00173720_m1 
Osteonectin SPARC NM_003118.2 Hs00234160_m1 
Runt-related 
transcription factor 2 
RUNX2 NM_001015051.3 Hs00231692_m1 
Cartilage oligomeric COMP NM_001920.3 Hs00164359_m1 
  
protein 
Matrix gla protein MGP NM_000900.3 Hs00969490_m1 
Thrombospondin 4 THBS4 NM_003248.4 Hs00170261_m1 
Fibromodulin FMOD NM_002203.3 Hs00158127_m1 
Fibronectin FN1 NM_212482.1 Hs00277509_m1 
Laminin LAMA NM_005559.3 Hs00300550_m1 
Aggrecan ACAN NM_0011353.3 Hs00153936_m1 
Versican VCAN NM_001126336.2 Hs01007933_m1 
Adhesion 
Integrin α1 ITGA1 NM_181501.1 Hs00235006_m1 
Integrin α2 ITGA2 NM_002203.3 Hs00201927_m1 
Integrin α3 ITGA3 NM_002204.2 Hs01076873_m1 
Integrin α4 ITGA4 NM_000885.4 Hs00168433_m1 
Integrin α5 ITGA5 NM_002205.2 Hs01547673_m1 
Integrin α6 ITGA6 NM_000210.2 Hs01041011_m1 
Integrin α10 ITGA10 NM_003637.3 Hs00174623_m1 
Integrin α11 ITGA11 NM_001004439.1 Hs00201927_m1 
Integrin β1 ITGB1 NM_002211.3 Hs00559595_m1 
Integrin β2 ITGB2 NM_000211.3 Hs00164957_m1 
Integrin β3 ITGB3 NM_000212.2 Hs01001469_m1 
Integrin β5 ITGB5 NM_002213.3 Hs00174435_m1 
CD44 CD44 NM_000610.3 Hs01075861_m1 
Housekeeping 
18S ribosomal RNA 18S rRNA  Hs99999901_s1 
Topoisomerase (DNA) I TOP1 NM_003286.2 Hs00243257_m1 
  
Eukaryotic translation 
initiation factor 4α 
EIF4α  Hs00756996_g1 
 
  
  
8. Figures 
Figure 1: For the tendon model, we induced an incision to the side of the leg (A) to expose the 
tendon by moving the skin (B). Using a 2 mm in diameter punch biopsy, we created a wound at the 
centre of the tendon, where the structured substrates were then inserted (C). The implants were 
secured using a PLGA film (D) and wounds were closed using biodegradable sutures (E). 
 
Figure 2: AFM analysis of isotropic (A) and structured (B, C, D) substrates. Quantification of 
isotropic control roughness, groove width, line width and groove depth (E). 
 
Figure 3: XPS analysis isotropic (Control) and structured substrates. Surface chemical analysis 
indicated no significant differences in elemental composition among all experimental topographical 
groups. Further, octadecyltrichlorosilane contamination was not detected, as evidenced by the 
absence of a chlorine peak at 198-200 eV. 
 
Figure 4: DAPI (blue) and rhodamine conjugated phalloidin (red) indicates that tenocytes aligned 
parallel to the substrate topography of groove depths of ~317 nm and ~1,988 nm, whilst a random 
morphology was observed on isotropic substrates and substrates with groove depth of ~37 nm (A). 
This was further confirmed, when the angle of cells parallel to the underlying topography was 
between 0 – 20 ° on substrates with groove depth of ~317 nm and ~1,988 nm (B). Substrates with 
groove depth of ~317 nm and ~1,988 nm induced the highest (p < 0.005) cytoskeleton elongation 
(D). No significant difference (p > 0.05) was observed in cellular area (C) and nuclei aspect ratio 
(E) as a function of surface topography. Note: Approximately 200 cells were used to assess the 
influence of surface topography on cellular morphology. 
 
Figure 5: Gene analysis demonstrates an overall gene upregulation at day 1 only on cells seeded on 
~1,988 nm in depth substrates, whilst at day 10 substrates with groove depth ~317 nm and ~1,988 
  
nm had more upregulated genes than substrates with groove depth of ~37 nm. At day 10, bone 
sialoprotein and aggrecan were upregulated on all substrates. 
 
Figure 6: Histological examination at the tendon repair site using haematoxylin-eosin staining 
showed a disorganised collagen fibre pattern for all implanted anisotropic substrates. Nuclei are 
stained blue, whereas cytoskeleton and extracellular matrix demonstrate varying degrees of pink 
staining. 
 
Figure 7: Histological analysis using Picrosirius Red staining and subsequent polarised light 
analysis demonstrated that by week 12 all treatments gave rise to collagen type I (yellow / red). At 
early time points (2 and 4 weeks) collagen type III (green) was evidenced. 
 
Figure 8: Collagen fibre morphometric analysis indicated that only non-injured tendons had 100% 
fibre distribution between -5 to 5 °, whilst the rest treatments exhibited less than 65% fibre 
distribution between -5 to 5 °. 
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